Kimberly-Clark/Kenvue: Deal That Would Create Consumer Goods Giant Enters Phase 2 Review in China; SAMR Minister Vacancy Could Figure into Delays on Merger Investigations

China’s antitrust authority has launched an in-depth review of consumer goods powerhouse Kimberly-Clark’s (KMB) proposed $48.7 billion acquisition of Tylenol maker Kenvue (KVUE), sources familiar with the matter said

Published on Aug 19, 2026

Already have an account? Log in.

This article is currently locked and only available to subscribers. Request a trial to receive unlimited access to all articles.

View Only Unlocked Articles

Copyright ©2026 The Capitol Forum. All Rights Reserved.